Skip to main content
Erschienen in: Medical Molecular Morphology 4/2017

19.06.2017 | Original Paper

Inclusion bodies of aggregated hemosiderins in liver macrophages

verfasst von: Hisao Hayashi, Yasuaki Tatsumi, Shinya Wakusawa, Ryota Shigemasa, Ryoji Koide, Ken-ichi Tsuchida, Natsuko Morotomi, Tetsuji Yamashita, Kotaro Kumagai, Yukiya Ono, Kazuhiko Hayashi, Masatoshi Ishigami, Hidemi Goto, Ayako Kato, Koichi Kato

Erschienen in: Medical Molecular Morphology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Hemosiderin formation is a structural indication of iron overload. We investigated further adaptations of the liver to excess iron. Five patients with livers showing iron-rich inclusions larger than 2 µm were selected from our database. The clinical features of patients and structures of the inclusions were compared with those of 2 controls with mild iron overload. All patients had severe iron overload with more than 5000 ng/mL of serum ferritin. Etiologies were variable, from hemochromatosis to iatrogenic iron overload. Their histological stages were either portal fibrosis or cirrhosis. Inclusion bodies were ultra-structurally visualized as aggregated hemosiderins in the periportal macrophages. X-ray analysis always identified, in addition to a large amount of iron complexes including oxygen and phosphorus, a small amount of copper and sulfur in the mosaic matrixes of inclusions. There were no inclusions in the control livers. Inclusion bodies, when the liver is loaded with excess iron, may appear in the macrophages as isolated organella of aggregated hemosiderins. Trace amounts of copper-sulfur complexes were always identified in the mosaic matrices of the inclusions, suggesting cuproprotein induction against excess iron. In conclusion, inclusion formation in macrophages may be an adaptation of the liver loaded with excess iron.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pietrangelo A (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139:393–408CrossRefPubMed Pietrangelo A (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139:393–408CrossRefPubMed
2.
Zurück zum Zitat Winter WE, Bazydlo LA, Harris NS (2014) The molecular biology of human iron metabolism. Lab Med 45:92–102CrossRefPubMed Winter WE, Bazydlo LA, Harris NS (2014) The molecular biology of human iron metabolism. Lab Med 45:92–102CrossRefPubMed
4.
Zurück zum Zitat Lillie RD (1939) Experiments on the solubility of hemosiderin in acids and other reagents during and after various fixations. Am J Pathol 15:225–239PubMedPubMedCentral Lillie RD (1939) Experiments on the solubility of hemosiderin in acids and other reagents during and after various fixations. Am J Pathol 15:225–239PubMedPubMedCentral
5.
Zurück zum Zitat Deugnier YM, Turlin B, Powell LW, Summers KM, Moirand R, Fletcher L, Loréal O, Brissot P, Halliday JW (1993) Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 17:30–34CrossRefPubMed Deugnier YM, Turlin B, Powell LW, Summers KM, Moirand R, Fletcher L, Loréal O, Brissot P, Halliday JW (1993) Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 17:30–34CrossRefPubMed
6.
Zurück zum Zitat Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783–788CrossRefPubMed Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783–788CrossRefPubMed
7.
Zurück zum Zitat Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093CrossRefPubMed Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093CrossRefPubMed
8.
Zurück zum Zitat Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1:191–200CrossRefPubMed Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1:191–200CrossRefPubMed
9.
Zurück zum Zitat Hattori A, Miyajima A, Tomosugi N, Tatsumi Y, Hayashi H, Wakusawa S (2012) Clinicopathological study of Japanese patients with genetic iron overload syndromes. Pathol Int 62:612–618CrossRefPubMed Hattori A, Miyajima A, Tomosugi N, Tatsumi Y, Hayashi H, Wakusawa S (2012) Clinicopathological study of Japanese patients with genetic iron overload syndromes. Pathol Int 62:612–618CrossRefPubMed
10.
Zurück zum Zitat Hayashi H, Wakusawa S, Yano M, Okada T (2007) Genetic background of Japanese patients with adult-onset storage diseases in the liver. Hepatol Res 37:777–783CrossRefPubMed Hayashi H, Wakusawa S, Yano M, Okada T (2007) Genetic background of Japanese patients with adult-onset storage diseases in the liver. Hepatol Res 37:777–783CrossRefPubMed
11.
Zurück zum Zitat Hawkins-Salsbury JA, Reddy AS, Sands MS (2011) Combined therapies for lysosomal storage disease: is the whole greater than the sum of its parts? Hum Mol Genet 20:R54–R60CrossRefPubMedPubMedCentral Hawkins-Salsbury JA, Reddy AS, Sands MS (2011) Combined therapies for lysosomal storage disease: is the whole greater than the sum of its parts? Hum Mol Genet 20:R54–R60CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Reuser AJ, Van Den Hout H, Bijvoet AG, Kroos MA, Verbeet MP, Van Der Ploeg AT (2002) Enzyme therapy for Pompe disease: from science to industrial enterprise. Eur J Pediatr 161(Suppl 1):S106–S111CrossRefPubMed Reuser AJ, Van Den Hout H, Bijvoet AG, Kroos MA, Verbeet MP, Van Der Ploeg AT (2002) Enzyme therapy for Pompe disease: from science to industrial enterprise. Eur J Pediatr 161(Suppl 1):S106–S111CrossRefPubMed
13.
Zurück zum Zitat Ono Y, Ishigami M, Hayashi K, Wakusawa S, Hayashi H, Kumagai K, Morotomi N, Yamashita T, Kawanaka M, Watanabe M, Ozawa H, Tai M, Miyajima H, Yoshioka K, Hirooka Y, Goto H (2015) Copper accumulates in livers of patients with iron overload syndromes. J Clin Transl Hepatol 3:85–92CrossRefPubMedPubMedCentral Ono Y, Ishigami M, Hayashi K, Wakusawa S, Hayashi H, Kumagai K, Morotomi N, Yamashita T, Kawanaka M, Watanabe M, Ozawa H, Tai M, Miyajima H, Yoshioka K, Hirooka Y, Goto H (2015) Copper accumulates in livers of patients with iron overload syndromes. J Clin Transl Hepatol 3:85–92CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Hanaichi T, Kidokoro R, Hayashi H, Sakamoto N (1984) Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab Invest 51:592–597PubMed Hanaichi T, Kidokoro R, Hayashi H, Sakamoto N (1984) Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab Invest 51:592–597PubMed
16.
Zurück zum Zitat Koyama C, Hayashi H, Wakusawa S, Ueno T, Yano M, Katano Y, Goto H, Kidokoro R (2005) Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J Hepatol 43:740–742CrossRefPubMed Koyama C, Hayashi H, Wakusawa S, Ueno T, Yano M, Katano Y, Goto H, Kidokoro R (2005) Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J Hepatol 43:740–742CrossRefPubMed
17.
Zurück zum Zitat Watanabe M, Asai C, Ishikawa K, Kiyota A, Terada T, Kono S, Miyajima H, Okumura A (2010) Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia. Intern Med 49:1581–1585 Watanabe M, Asai C, Ishikawa K, Kiyota A, Terada T, Kono S, Miyajima H, Okumura A (2010) Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia. Intern Med 49:1581–1585
18.
Zurück zum Zitat Tstuchida K, Taneda S, Misawa K, Akimoto Y, Bando H, Hagiwara S, Komori K, Hattori A, Tatsumi Y, Hayashi H, Nakayama H, Mada N (2010) Novel compound heterozygote mutations in a Japanese patient with hemochromatosis who has severe diabetes, pituitary hypogonadism and liver fibrosis. Diabetes 53:247–252 (in Japanese) Tstuchida K, Taneda S, Misawa K, Akimoto Y, Bando H, Hagiwara S, Komori K, Hattori A, Tatsumi Y, Hayashi H, Nakayama H, Mada N (2010) Novel compound heterozygote mutations in a Japanese patient with hemochromatosis who has severe diabetes, pituitary hypogonadism and liver fibrosis. Diabetes 53:247–252 (in Japanese)
19.
Zurück zum Zitat Yamashita T, Morotomi N, Sohda T, Hayashi H, Yoshida N, Ochi K, Ohkura I, Karita M, Fujiwara H, Yamashita H, Hattori A, Tatsumi Y (2014) A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B. Clin J Gastroenterol 7:260–264CrossRefPubMed Yamashita T, Morotomi N, Sohda T, Hayashi H, Yoshida N, Ochi K, Ohkura I, Karita M, Fujiwara H, Yamashita H, Hattori A, Tatsumi Y (2014) A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B. Clin J Gastroenterol 7:260–264CrossRefPubMed
20.
Zurück zum Zitat Kaneko Y, Miyajima H, Piperno A, Tomosugi N, Hayashi H, Morotomi N, Tsuchida K, Ikeda T, Ishikawa A, Ota Y, Wakusawa S, Yoshioka K, Kono S, Pelucchi S, Hattori A, Tatsumi Y, Okada T, Yamagishi M (2010) Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders. J Gastroenterol 45:1163–1171CrossRefPubMed Kaneko Y, Miyajima H, Piperno A, Tomosugi N, Hayashi H, Morotomi N, Tsuchida K, Ikeda T, Ishikawa A, Ota Y, Wakusawa S, Yoshioka K, Kono S, Pelucchi S, Hattori A, Tatsumi Y, Okada T, Yamagishi M (2010) Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders. J Gastroenterol 45:1163–1171CrossRefPubMed
21.
Zurück zum Zitat Kurz T, Eaton JW, Brunk UT (2011) The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol 43:1686–1697CrossRefPubMed Kurz T, Eaton JW, Brunk UT (2011) The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol 43:1686–1697CrossRefPubMed
23.
Zurück zum Zitat Vashchenko G, MacGillivray RT (2013) Multi-copper oxidases and human iron metabolism. Nutrients 27:2289–2313CrossRef Vashchenko G, MacGillivray RT (2013) Multi-copper oxidases and human iron metabolism. Nutrients 27:2289–2313CrossRef
24.
Zurück zum Zitat Zhao M, Matter K, Laissue JA, Zimmermann A (1995) Copper/zinc and manganese superoxide dismutase immunoreactivity in hepatic iron overload diseases. Histol Histopathol 10:925–935PubMed Zhao M, Matter K, Laissue JA, Zimmermann A (1995) Copper/zinc and manganese superoxide dismutase immunoreactivity in hepatic iron overload diseases. Histol Histopathol 10:925–935PubMed
25.
Zurück zum Zitat Schröder JM (2005) Ferritinopathy: diagnosis by muscle or nerve biopsy, with a note on other nuclear inclusion body diseases. Acta Neuropathol 109:109–114CrossRefPubMed Schröder JM (2005) Ferritinopathy: diagnosis by muscle or nerve biopsy, with a note on other nuclear inclusion body diseases. Acta Neuropathol 109:109–114CrossRefPubMed
26.
Zurück zum Zitat Yoshida K, Hayashi H, Wakusawa S, Shigemasa R, Koide R, Ishikawa T, Tatsumi Y, Kato K, Ohara S (2017) Ikeda SI (2016) Coexistence of copper in the iron-rich particles of aceruloplasminemia brain. Biol Trace Elem Res 175:79–86CrossRefPubMed Yoshida K, Hayashi H, Wakusawa S, Shigemasa R, Koide R, Ishikawa T, Tatsumi Y, Kato K, Ohara S (2017) Ikeda SI (2016) Coexistence of copper in the iron-rich particles of aceruloplasminemia brain. Biol Trace Elem Res 175:79–86CrossRefPubMed
27.
Zurück zum Zitat Vidal R, Ghetti B, Takao M, Brefel-Courbon C, Uro-Coste E, Glazier BS, Siani V, Benson MD, Calvas P, Miravalle L, Rascol O, Delisle MB (2004) Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Experiment Neurol 63:363–380CrossRef Vidal R, Ghetti B, Takao M, Brefel-Courbon C, Uro-Coste E, Glazier BS, Siani V, Benson MD, Calvas P, Miravalle L, Rascol O, Delisle MB (2004) Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Experiment Neurol 63:363–380CrossRef
Metadaten
Titel
Inclusion bodies of aggregated hemosiderins in liver macrophages
verfasst von
Hisao Hayashi
Yasuaki Tatsumi
Shinya Wakusawa
Ryota Shigemasa
Ryoji Koide
Ken-ichi Tsuchida
Natsuko Morotomi
Tetsuji Yamashita
Kotaro Kumagai
Yukiya Ono
Kazuhiko Hayashi
Masatoshi Ishigami
Hidemi Goto
Ayako Kato
Koichi Kato
Publikationsdatum
19.06.2017
Verlag
Springer Japan
Erschienen in
Medical Molecular Morphology / Ausgabe 4/2017
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI
https://doi.org/10.1007/s00795-017-0163-x

Weitere Artikel der Ausgabe 4/2017

Medical Molecular Morphology 4/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie